Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-20

FDA Approved: AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05% — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic azelastine hydrochloride ophthalmic solution 0.05% under an Original Application (ANDA) for Alembic Pharmaceuticals. The approval support…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05% (azelastine hydrochloride ophthalmic solution 0.05%)

Snippet

ORIG AP for AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05% (AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.05%)